GLP-1 drugs may reduce asthma symptoms in obese adults, offering a steroid-free alternative to treatment. The study includes ...

Mounjaro kick-started my weight loss, but true success came from hard work, persistence and changing bad habits ...

Neuroscientist Sabina Brennan encourages caregivers to live in the moment and notice the happy experiences they share with ...

Key messages • It is known that older people who take more medicines with an anticholinergic effect may be at greater risk of cognitive decline. • There is a lack of high-quality evidence to show ...

Dementia has become a public health burden worldwide. Caring for people with dementia is highly stressful, thus carers are more likely to suffer from psychological problems, such as depression and ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

The 24-year study of more than 1.2 million children in Denmark found that aluminum exposure didn't raise the risk of autism, asthma, or other chronic diseases. Other science and research news is on ...

A new study warns that this prescription drug can significantly increase the risk of dementia and mild cognitive impairment in people taking it for chronic low back pain.

The World Health Organisation (WHO) has issued a global alert regarding fraudulent versions of Ozempic, which have grown popular as a weight-loss method. Despite its primary purpose as a type 2 ...

Oxygen reduction reaction (ORR), operating via four-electron (H2O) or two-electron (H2O2) pathways, underpins critical processes in energy conversion and biological metabolism. Solid–liquid contact ...